Post

New research · Ophthalmology
Pediatric rheumatology online journal · 2d
ReviewPediatric rheumatology online journal · 2026

Identifying outcome measures for clinical trials in juvenile idiopathic arthritis associated uveitis for the MIWGUC proposal: a scoping review to create domains from existing outcome measures.

Ilaria Maccora, Giulia Inguscio, Stefano Romano … Gabriele Simonini
Read paper
OphthalmologyReview

Studies use 15 different outcome measures to track juvenile arthritis-related eye inflammation.

Identifying outcome measures for clinical trials in juvenile idiopathic arthritis associated uveitis for the MIWGUC proposal: a scoping review to create domains from existing outcome measures.

Ilaria Maccora … Gabriele Simonini
Pediatric rheumatology online journal · 2026
Background

Chronic anterior uveitis represents the most important extra-articular manifestation of Juvenile Idiopathic Arthritis (Juvenile Idiopathic Arthritis).

Methods

We performed a systematic literature review from 1st January 2019 to 28th February 2025 to identify studies investigating outcome measures used in Juvenile Idiopathic Arthritis-associated uveitis (Juvenile Idiopathic Arthritis-U), according to PRISMA guidelines.

n = 37 studies
15
Results
15
researchers checked eye inflammation in different, inconsistent ways across studies
n = 37 studies
More results

We identified 261 papers, of whom 90 potentially eligible.

Based on their characteristics, we categorized them into three different subgroups: outcome measures for disease activity (30 studies); outcome measures correlated to structural damage (29 studies); and outcome measures of severe disease course (20 studies).

More results

Compared with the 2019 review, we identified four studies reporting novel objective techniques for inflammation assessment, including laser flare photometry and anterior segment optical coherence tomography.

“
Conclusion · 1 of 2

Our review confirms the variety of outcome measures for JIA-associated uveitis while highlighting the emergence of novel imaging and biomarker-based measures.

Conclusion · 2 of 2

These findings provide an updated evidence base for revising the core outcome set and emphasize the urgent need for a consensus and a composite score, which are essential both for designing endpoints in clinical trials and for guiding treatment choices in clinical practice.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving